G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia

Annals of Clinical and Laboratory Science

Volumn 38, Issue 4, 2008, Pages 331-337

  Lee, Jehoon ^a   Kim, Yonggoo ^a   Lim, Jihyang ^a   Kim, Myungshin ^a   Han, Kyungja ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Chronic myelogenous leukemia (CML); G CSF receptor; GM CSF receptor; Granulocyte colony stimulating factor (G CSF); Granulocyte macrophage colony stimulating factor (GM CSF)

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;

ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CELL COUNT; CELL STRUCTURE; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; GRANULOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; RECEPTOR BINDING;

ADULT; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTES; MALE; MONOCYTES; NEUTROPHILS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 55949083080     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Anderlini P, Przepiorka D, Champlin R, Korbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88:2819-2825.
2. Layton JE, Hall NE. The interaction of G-CSF with its receptor. Front Biosci 2006;11:3181-3189.
3. Shinjo K, Takeshita A, Ohnishi K, Ohno R. Granulocyte colony-stimulating factor receptor at various differendation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma 1997;25:37-46.
4. Lee KY, Suh BG, Kim JW, Lee W, Kim SY, Kim YY, Lee J, Lim J, Kim M, Kang CS, Han K. Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes. Exp Mol Med 2000;32: 210-215.
5. Spooner E, Fairbairn L, Cowling GJ, Dexter TM, Whetton AD, Owen-Lynch PJ. Biological consequences of the p160v-abl protein tyrosine kinase activity in a primitive, multipotent haematopoietic cell line. Leukemia 1994;8:620-630.
6. Carlesso N, Griffin JD, Drucker BJ. Use of a temperature-sensitive mutant to define the biological effects of the p210bcr-abl tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 1994;9: 149-156.
7. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR/ABL in chronic myeloid leukemia. Blood 1994;83:2038-2044.
8. Cortez D, Kadec L, Pendergast AM. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol 1995;15:5531-5541.
9. Naparstek E, Granulocyte colony-stimulating factor, congenital neutropenia, and acute myeloid leukemia. NEJM 1995;24:516-518.
10. Carapeti M, Soede-BobokA, Hochhaus A, Sill H, Touw IP, Goldman JM, Cross NC. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia. Leukemia 1997;11:1005-1008.
11. Freeburn RW, Gale RE, Wagner HM, Linch DC. Analysis of the coding sequence for the GM-CSF receptor alpha and beta chains in patients with juvenile chronic myeloid leukemia (JCML). Exp Hematol 1997; 25:306-311.
12. Brown AL, Peters M, D'Andrea RJ, Gonda TJ. Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation. Blood 2004;103:507-516.
13. Hustinx WN, Van Kessel CP, Heezius E, Burgers S, Lammers JW, Hoepelman IM. Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia. Clin Exp Immunol 1998;112:334-340.
14. Terashi K, Oka M, Ohdo S, Furukubo T, Ikeda C, Fukuda M, Soda H, Higuchi S, Kohno S. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients. Antimicrob Agents Chemother 1999;43:21-24.
15. Busch FW, Pilgrim TB, Kramer A, Ehninger G. Plasma levels of granulocyte colony-stimulating factor in patients after allergenic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow. Bone Marrow Transpl 1997;19: 653-659.
16. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haematopoietic cells. Nature 1989;339:27-30.
17. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994;84:1737-1746.
18. Betsuyaku T, Liu F, Senior RM, Haug JS, Brown EJ, Jones SL, Matsushima K, Link DC. A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation. J Clin Invest 1999;103:825-832.
19. Dong F, Brynes RK, Tidow N, Weite K, Löwenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. NEJM 1995;333:487-493.
20. Cyopick P, Culliton R, Brockhausen I, Sutherland DR, Mills GB, Baker M. Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. Leuk Lymphoma 1993;11:79-90.